Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Liver Micro Flow - MRI

NCT: NCT07634939 · NOT_YET_RECRUITING

NCT IDNCT07634939
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2029-05
SponsorUniversity of Wisconsin, Madison (OTHER)
First posted
Last updated

Brief Summary

This study integrates and evaluates a series of novel MRI methods for quantifying blood perfusion and tissue microstructure. The proposed perfusion and microstructure measures may provide biomarkers for fibrosis, cirrhosis, portal hypertension, and response to treatment. The precision of these methods will be evaluated in 110 participants, including healthy volunteers, people with chronic liver disease (CLD), and people with liver fibrosis.

Frequently Asked Questions

What is Liver Micro Flow - MRI?

Liver Micro Flow - MRI is a clinical trial registered under NCT07634939. Current status: NOT_YET_RECRUITING.

What is the status of NCT07634939?

The current status of NCT07634939 (Liver Micro Flow - MRI) is: NOT_YET_RECRUITING.

When did Liver Micro Flow - MRI start?

Liver Micro Flow - MRI started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.